Patient data is only as useful as the report that delivers it. The Ameritox Rx GuardianSM results report provides the most in-depth information available on your patients’ pain medication use in a detailed, yet easy-to-interpret format.
- The normalized value adjusts the laboratory result for certain physiologic variables, such as body mass and hydration level, using creatinine and lean body weight (height, weight, and gender).
- The normalized value is compared to a dynamic database of chronic pain patients who have been clinically assessed for medication adherence.
- The normalized value is then converted to a standard score. Both the normalized value and standard score results are displayed on the Rx GuardianSM Results Report.
- The curve on the report represents the distribution of standard scores of patients who were clinically assessed as adherent in the reference database taking a particular medication. Your patient’s standard score is plotted on the curve to visually demonstrate this comparison.
- Less than 5 percent of patients clinically assessed as adherent in the Rx Guardian CDSM database have standard scores of less than -2.0 or greater than +2.0.
- Less than 1 percent of patients clinically assessed as adherent in the Rx Guardian CDSM database have standard scores of less than -3.0 or greater than +3.0.
- Rx Guardian CDSM enables clinicians to compare their patients’ normalized urine drug levels to the population of actual pain patients in the reference database.
- Because the 95 percent Database Reference Range will always be -2 to +2, you can continue to assess results over time regardless of changes in dose to the same medication.
- Rx GuardianSM results should be considered in context of the complete clinical picture, including behavioral assessments and knowledge of the patient. Rx GuardianSM is and has always been one valuable, but never the only, source of evidence about medication adherence.
Note: The 95 percent Database Reference Ranges are rounded from +1.96 and -1.96.